Medical Science Liaison - Epilepsies
Praxis Precision Medicines, Inc.
| Company | Praxis Precision Medicines, Inc. |
| Category | Healthcare |
| Location | United States - Remote |
| Remote | Remote |
| Employment | Not stated |
| Level | Not stated |
| Salary | Not stated by the employer |
| Posted | 15 Apr 2026 |
| Last verified | 12 Aug 2026 |
| Source | Employer ATS (greenhouse) |
Description
Location: This position may be performed remotely, but requires the flexibility and willingness to travel as needed.
The Opportunity
Praxis is seeking a field-based Medical Science Liaison (MSL) to support Medical Affairs activities for relutrigine during pre-launch and potential launch. This role is focused on building trusted scientific partnerships with a defined set of high-priority academic and community neurology centers, delivering high-quality scientific exchange, and generating actionable insights to inform medical strategy and ensure clinical readiness.
This is a field-facing, development-oriented role operating within a highly focused engagement model, where you will engage healthcare professionals managing rare and developmental epilepsies. You will communicate emerging clinical data, deepen disease state understanding, and identify unmet needs and potential barriers to patient care.
Working closely with internal, cross-functional partners to support aligned and compliant execution of pre-launch and launch activities in a dynamic and evolving environment.
Success in this role requires strong scientific curiosity, effective communication skills, and the ability to engage in complex clinical discussions while continuing to build confidence and independence in the field.
Primary Responsibilities
Build and maintain scientific relationships with healthcare professionals, investigators, and key opinion leaders at a defined set of priority academic and community neurology centers
Deliver accurate, balanced, and compliant scientific exchange on disease state, clinical data, and the relutrigine clinical profile, including complex discussions in rare and genetic epilepsies
Support pre-launch medical readiness by educating stakeholders on emerging data, evolving treatment paradigms, and patient identification considerations in SCN2A and SCN8A populations
Engage in deep scientific dialogue on mechanism of action, genotype–phenotype relationships, and clinical data interpretation in rare patient populations
Gather, synthesize, and communicate field insights (e.g., unmet needs, diagnostic challenges, treatment patterns, clinical questions) to inform medical strategy
Support identification and engagement of key experts and specialized epilepsy centers under the guidance of senior team members
Collaborate cross-functionally with internal teams to ensure aligned execution of field activities and support clinical readiness
Represent Praxis at scientific congresses and medical meetings, capturing and translating insights into actionable recommendations
Maintain up-to-date knowledge of rare epilepsy landscapes, clinical data, and emerging scientific developments
Ensure all field activities are conducted in compliance with regulatory requirements, company policies, and industry standards
Qualifications and Key Success Factors
Advanced clinical or scientific degree (PharmD, PhD, MD, NP, PA, or RN)
Early to mid-career experience in medical affairs, clinical practice, clinical research, or related roles in biotech/pharma
Strong ability to learn and communicate scientific and clinical information clearly and credibly
Demonstrated ability to build professional relationships with healthcare providers
Interest in developing field-based expertise, including insight gathering and scientific engagement
Ability to manage multiple priorities with strong organization and attention to detail
Willingness to travel extensively (~60–80%)
Experience in neurology or CNS disorders preferred
Exposure to p